SPOTLIGHT -
Fort Lauderdale, FL-Frequency doubling technology (FDT) perimetry appears to be a more sensitive visual field test for ganglion cell loss than traditional testing methods, according to Christopher A. Girkin, MD.
EyePoint Pharmaceuticals announces positive topline data from Phase 2 DAVIO 2 trial of EYP-1901 in Wet AMD
Week in Review - November 26, 2023
Sonepur District Headquarters Hospital ophthalmologist caught taking bribes to conduct surgery
Week in Review - November 12, 2023
Syphilitic Uveitis surges in the US
Corza Medical opens its Ophthalmology Center of Technology and Innovation